Survival probability in ataxia telangiectasia
- PMID: 16790721
- PMCID: PMC2082822
- DOI: 10.1136/adc.2006.094268
Survival probability in ataxia telangiectasia
Abstract
Ataxia telangiectasia is a rare, multiorgan neurodegenerative disorder with enhanced vulnerability to cancer and infection. Median survival in two large cohorts of patients with this disease, one prospective and one retrospective, is 25 and 19 years, with a wide range. Life expectancy does not correlate well with severity of neurological impairment.
Conflict of interest statement
Competing interests: none declared
References
-
- Sedgwick R P, Boder E. Ataxia telangiectasia. In: Vinken PJ, Bruyn GW, Klawans HL, et al, editors. Hereditary neuropathies and spinocerebellar atrophies, vol 60, Handbook of clinical neurology. Amsterdam: Elsevier, 1991347–423.
-
- Morrell D, Cromartie E, Swift M. Mortality and cancer incidence in 263 patients with ataxia Telangiectasia. J Natl Cancer Inst 19867789–92. - PubMed
-
- Therneau T M, Grambsch P M.Modeling survival data: extending the Cox model. New York: Springer‐Verlag, 2000
-
- Lin D Y, Wei L J. The robust inference for the Cox proportional hazards model. J Am Stat Assoc 1989841074–1078.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical